AMBIENTUM BIOETHICA BIOLOGIA CHEMIA DIGITALIA DRAMATICA EDUCATIO ARTIS GYMNAST. ENGINEERING EPHEMERIDES EUROPAEA GEOGRAPHIA GEOLOGIA HISTORIA HISTORIA ARTIUM INFORMATICA IURISPRUDENTIA MATHEMATICA MUSICA NEGOTIA OECONOMICA PHILOLOGIA PHILOSOPHIA PHYSICA POLITICA PSYCHOLOGIA-PAEDAGOGIA SOCIOLOGIA THEOLOGIA CATHOLICA THEOLOGIA CATHOLICA LATIN THEOLOGIA GR.-CATH. VARAD THEOLOGIA ORTHODOXA THEOLOGIA REF. TRANSYLVAN
The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary
The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.
Authors: IOANA-NICOLETA LINCA, SILVIA IMRE, IOAN TOMUȚĂ, AMELIA TERO-VESCAN.
DOI: 10.24193/subbchem.2022.1.02
Published Online: 2021-03-15
Published Print: 2021-03-30
pp. 27-41
VIEW PDF
FULL PDF
Clopidogrel is a chiral compound, (+)-(S)-enantiomer has antiplatelet activity, while (-)-(R)-clopidogrel is considered an impurity of the active substance. The development of HPLC methods for optical purity analysis involves the use of expensive chiral columns and the methodologies could be different in the two well recognized compendia, European (Ph.Eur.) and United Stated (USP) Pharmacopoeias. The aim of this study was to optimise the chiral chromatographic assay of clopidogrel and its impurities from tablets taking into consideration the official pharmacopoeia provision by testing the influence of the variation of different chromatographic parameters on the relative retention times of clopidogrel and official impurities in order to achive the separation performance parameters described in USP43. HPLC-UV enantioseparation of clopidogrel was performed on a column with ovomucoid as a stationary phase chiral selector and phosphate – acetonitrile mixtures as mobile phase. The official relative retention of clopidogrel and its A and C impurities could not be achieved in this study, neither by applying a classical optimization methodology nor by using the experimental design methodology which raises the issue of reviewing the pharmacopoeia provisions. A comparative discussion between the two different approaches regarding chiral separation of clopidogrel in Ph.Eur. and USP is provided.
Keywords: clopidogrel, chiral separation, HPLC, ovomucoid, enantioseparation.
